Correlation Between Monopar Therapeutics and CITIGROUP

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and CITIGROUP at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and CITIGROUP into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and CITIGROUP INC, you can compare the effects of market volatilities on Monopar Therapeutics and CITIGROUP and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of CITIGROUP. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and CITIGROUP.

Diversification Opportunities for Monopar Therapeutics and CITIGROUP

-0.65
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Monopar and CITIGROUP is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and CITIGROUP INC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CITIGROUP INC and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with CITIGROUP. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CITIGROUP INC has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and CITIGROUP go up and down completely randomly.

Pair Corralation between Monopar Therapeutics and CITIGROUP

Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 17.87 times more return on investment than CITIGROUP. However, Monopar Therapeutics is 17.87 times more volatile than CITIGROUP INC. It trades about 0.4 of its potential returns per unit of risk. CITIGROUP INC is currently generating about -0.21 per unit of risk. If you would invest  2,200  in Monopar Therapeutics on November 1, 2024 and sell it today you would earn a total of  2,050  from holding Monopar Therapeutics or generate 93.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.24%
ValuesDaily Returns

Monopar Therapeutics  vs.  CITIGROUP INC

 Performance 
       Timeline  
Monopar Therapeutics 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Monopar Therapeutics are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Monopar Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
CITIGROUP INC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CITIGROUP INC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, CITIGROUP is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Monopar Therapeutics and CITIGROUP Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monopar Therapeutics and CITIGROUP

The main advantage of trading using opposite Monopar Therapeutics and CITIGROUP positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, CITIGROUP can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CITIGROUP will offset losses from the drop in CITIGROUP's long position.
The idea behind Monopar Therapeutics and CITIGROUP INC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.